Premium
Mid-market private equity firm Jacob Ballas Capital has marked its third liquidity event this year as it looks to harvest its investments from its last India-focused funds raised almost a decade ago.The firm has part-exited active pharmaceutical ingredients (API) and chemicals maker Vivimed Labs Ltd last week, its second such ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
